 Home > Medical News > Latest Medical News > UCB Fintepla Receives FDA Approval for Expanded Indications

UCB Fintepla Receives FDA Approval for Expanded Indications

 Last Update: 2022-05-26
 Source: Internet
 Author: User

Tags

co treatment

viibryd 10 mg

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 28, 2022, UCB (UCB) announced that the U.

LGS is a severe childhood-onset developmental and epileptic encephalopathy (DEE) characterized by a high incidence of drug-refractory seizures and severe impairment of neurodevelopmental, cognitive, and motor function

Fintepla is a low-dose fenfluramine in liquid form

picture

The Phase 3 clinical trial enrolled 263 LGS patients (age range: 2-35 years)

References:

[1] US FDA Approves FINTEPLA® ▼(fenfluramine) Oral Solution for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS).

Note: The original text has been deleted

Original title: Express | Approved again in the field of epilepsy, the prospect of fenfluramine "old drug new" can be expected

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.